Axios incorrectly reported on Tuesday that the Food and Drug Administration had signed off on a new and faster type of coronavirus test. We have removed that inaccurate story from our website.

What happened: A medical distribution company called Bodysphere said in a press release that the FDA had granted an “emergency use authorization” that could allow patients to get a diagnosis in only about two minutes.

Axios reprinted that incorrect information, based on the press release.

But the FDA confirmed Wednesday that it has not issued such an authorization. No two-minute diagnosis is available.

Axios' policy is to correct our mistakes and not to delete them.